Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The topical vehicle as a key factor in the management of the psoriatic patients' therapy.

Vertuani S, Cvetkovska AD, Zauli S, Virgili A, Manfredini S, Bettoli V.

G Ital Dermatol Venereol. 2013 Dec;148(6):679-85. Review.

PMID:
24442051
2.

Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis.

Eastman WJ, Malahias S, Delconte J, DiBenedetti D.

Cutis. 2014 Jul;94(1):46-53.

PMID:
25101344
3.

[Corticosteroids and their vehicle in the treatment of scalp psoriasis].

Wauters O, Roland I, De la Brassinne M.

Rev Med Liege. 2007 Apr;62(4):196-9. Review. French.

PMID:
17566388
4.

[Psoriasis--clinical picture and current therapy].

Shakery K, Reich K.

Med Monatsschr Pharm. 2009 Sep;32(9):335-44; quiz 345-6. Review. German.

PMID:
19795696
5.

[Topical treatments for psoriasis in 2009].

Thielen AM, Laffitte E.

Rev Med Suisse. 2009 Apr 22;5(200):876, 878-81. Review. French.

PMID:
19438087
6.

Combination therapy of biologics with traditional agents in psoriasis.

Guenther LC.

Skin Therapy Lett. 2011 Jun;16(6):1-3.

7.

Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference.

Housman TS, Mellen BG, Rapp SR, Fleischer AB Jr, Feldman SR.

Cutis. 2002 Dec;70(6):327-32.

PMID:
12502121
8.

Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance.

Jackson JM, Pelle M.

J Drugs Dermatol. 2011 Jun;10(6):627-33. Review.

PMID:
21637903
9.

Are ointments better than other vehicles for corticosteroid treatment of psoriasis?

Zivkovich AH, Feldman SR.

J Drugs Dermatol. 2009 Jun;8(6):570-2.

PMID:
19537382
10.

[Infliximab].

Herrera E, Habicheyn S.

Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:7-13. Review. Spanish.

PMID:
19080986
11.

[News on psoriasis from the 2010 Dermatology Days in Paris].

Boulinguez S.

Ann Dermatol Venereol. 2011 May;138(5 Suppl 1):H1-5. doi: 10.1016/S0151-9638(11)70064-3. French. No abstract available.

PMID:
21703458
12.

[Therapeutic strategies for psoriasis and psoriatic arthritis].

Wozel G.

Hautarzt. 2009 Feb;60(2):91-9. doi: 10.1007/s00105-008-1662-4. Review. German.

PMID:
19183912
13.

Management of psoriasis with calcipotriol used as monotherapy.

Ramsay CA.

J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S53-4. Review.

PMID:
9344185
14.

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting.

Bonafede M, Johnson BH, Fox KM, Watson C, Gandra SR.

J Dermatolog Treat. 2013 Oct;24(5):369-73. doi: 10.3109/09546634.2012.755255. Epub 2013 May 21.

15.

Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.

Campione E, Mazzotta A, Paternò EJ, Diluvio L, Prinz JC, Chimenti S.

Acta Derm Venereol. 2009;89(3):288-91. doi: 10.2340/00015555-0585.

16.

[Our experience with infliximab in reclacitrant cases of psoriasis].

Pereiro M Jr, González-Vilas D, Sánchez-Aguilar D, Toribio J.

Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:43-7. Spanish.

PMID:
19080991
17.

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R.

J Am Acad Dermatol. 2009 Sep;61(3):451-85. doi: 10.1016/j.jaad.2009.03.027. Epub 2009 Jun 3.

PMID:
19493586
18.

Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.

Prinz JC, Fitzgerald O, Boggs RI, Foehl J, Robertson D, Pedersen R, Molta CT, Freundlich B.

J Eur Acad Dermatol Venereol. 2011 May;25(5):559-64. doi: 10.1111/j.1468-3083.2010.03838.x. Epub 2010 Sep 14.

PMID:
20840349
19.

The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.

Krueger GG, Drake LA, Elias PM, Lowe NJ, Guzzo C, Weinstein GD, Lew-Kaya DA, Lue JC, Sefton J, Chandraratna RA.

Arch Dermatol. 1998 Jan;134(1):57-60.

PMID:
9449910
20.

Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.

Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L.

Eur J Dermatol. 2010 Jul-Aug;20(4):465-71. doi: 10.1684/ejd.2010.0948. Epub 2010 Apr 23.

PMID:
20413372

Supplemental Content

Support Center